Tag Archives: informed consent
Sildenafil Use and Increased Risk of Inciden… [JAMA Intern Med. 2014] – PubMed – NCBI
JAMA Intern Med. 2014 Jun 1;174(6):964-70. doi: 10.1001/jamainternmed.2014.594. Sildenafil Use and Increased Risk of Incident Melanoma in US Men: A Prospective Cohort Study. Li WQ1, Qureshi AA2, Robinson KC3, Han J4. Author information Abstract IMPORTANCE The RAS/RAF/mitogen-activated protein kinase and … Continue reading →
The top online health services for consumers | VentureBeat | Health | by Christina Farr
Interesting line-up of online medical shopping/info sites. Some might offer some relief from/price-conscious alternatives to emergency room visits. Perhaps good news for U.S. patients facing gigantic out-of-pocket expenses for not-sure-what value-add, a worldwide market for digital medical tourism for low-complexity … Continue reading →
The Selling of Attention Deficit Disorder – NYTimes.com
Surprisingly critical, thoroughly researched piece by Alan Schwarz. See also recent posts here (on opening the gigantic Asian market to Western psychotropics), here (on Allen Roses critique of drug efficacy), here (on the DSM V’s focus on, well, drug treatment), … Continue reading →
A surprisingly uncritical piece on Big Pharma’s unfettered hold on China’s health care
Not that medications do not have a place in the treatment armamentarium, but what about proper, expertise-based diagnosis first? What about the undisclosed conflicts of interest rampant in Chinese hospitals? Informed consent? Both an outsized version of the situation in … Continue reading →
Metabolic Fate of Pharmaceuticals: A Focus on Slow Metabolizers
Very interesting and timely PowerPoint focusing on (now increasingly preventable) adverse outcomes, not on metabolism-related lack of efficacy. >>It has been shown that variability in drug metabolism can have a substantial effect on clinical outcomes in patients. The impact of … Continue reading →